Mastermind Session: How Can We Achieve Potency & Durability of Response for More Successful Clinical Outcomes?
Time: 10:30 am
day: Advancing Durability & Persistence Focus Day
- Discussing why, when compared to the autologous approach, allogeneic therapies are experiencing major issues with durability
- Investigating reactivation of endogenous immunity from the patient donor’s immunity following allogeneic T-cell infusion
- Exploring the balance between long-lasting persistence versus the efficacy of the transient allogeneic product
- Discussing innovations in design and administration to develop a long acting allogeneic cell therapy